Research and Development: Page 2

‘Remarkable’ results in lupus patients spark speculation CAR-T may cure autoimmunity

By Nick Paul Taylor

The generation of “remarkable” results in lupus patients has sparked speculation about the potential for chimeric antigen receptor T-cell (CAR-T cell) therapy to cure autoimmune diseases.

February 23, 2024

CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

By LabPulse.com staff writers

CARB-X will award up to $1.8 million to biotech firm Visby Medical to develop a portable rapid polymerase chain reaction test to detect Neisseria gonorrhoeae, the pathogen that causes gonorrhea, including its susceptibility to ciprofloxacin.

February 8, 2024

U.K. trial for mRNA-based cancer therapy begins

By Matt Limb

Cancer patients in the U.K. are receiving an experimental mRNA therapy designed to help their bodies recognize and fight cancer cells.

February 7, 2024

BioMérieux, UPitt in new three-year agreement

By LabPulse.com staff writers

BioMérieux and the University of Pittsburgh have entered into a three-year diagnostics research agreement, the university announced in Pittwire.

February 2, 2024

Sensorion receives clinical trial approval for congenital deafness gene therapy

By LabPulse.com staff writers

French biotech firm Sensorion has received approval to initiate a phase I and II clinical trial in France of SENS-501 (the OTOF-GT program), its gene therapy for gene-mediated hearing impairment.

January 22, 2024

IGI, Danaher launch CRISPR gene therapy research center

By LabPulse.com staff writers

Danaher and the Innovative Genomics Institute (IGI) have launched a collaborative research center aimed at developing CRISPR-based gene therapies for a wide array of diseases.

January 12, 2024

Labcorp continues clinical trial drive

By LabPulse.com staff writers

In another move to build a strong foundation for its clinical trial testing business, Labcorp has announced that it will collaborate with Hawthorne Effect for decentralized clinical trial support at home and in the community.

January 10, 2024

Thermo Fisher goes big with new pangenome array

By LabPulse.com staff writers

Thermo Fisher Scientific announced the launch of a new human genomics research tool that complements the recent development of the pangenome.

January 5, 2024

Algorithm for drug repurposing unveiled at NeurIPS

By LabPulse.com staff writers

A team at Klick Applied Sciences have created an artificial intelligence (AI) framework that can identify new indications for existing drugs.

January 2, 2024

$2.4M NIH Wadsworth lab grant supports more exposome studies

By LabPulse.com staff writers

The NIH has awarded the Wadsworth Center Health Exposure Analysis Research (HHEAR) laboratory hub $2.4 million to continue studies of the exposome.

December 15, 2023

King's College London, bit.bio collaboration launched to build multicell brain models

By Matt Limb

A collaboration has been launched in the U.K. to build multicell models of the human brain deemed vital to develop novel therapies for neuronal and psychiatric disorders.

December 5, 2023

UK Biobank shares 500K WGS linked to 15 years of health data

By Nick Paul Taylor

UK Biobank has made deidentified whole genome sequencing (WGS) data on 500,000 people available, enabling researchers around the world to analyze the genomics results alongside 15 years of health data on the individuals.

December 4, 2023

Previous Page

Page 2 of 38

Next Page